Indicators

Markets:

News

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9

...

Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock

September 05, 2024

Weight loss drugs cut Covid-19 deaths, study finds

September 02, 2024

CNBC Daily Open: Everyone's waiting for Nvidia

August 28, 2024

CNBC Daily Open: Stocks up ahead of Nvidia earnings

August 27, 2024

5 things to know before the stock market opens Tuesday

August 27, 2024

Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply

August 27, 2024

Friday's big stock stories: What’s likely to move the market in the next trading session

August 22, 2024

CNBC Daily Open: A 'crazy' summer

August 21, 2024

CNBC Daily Open: 'Crazy' summer

August 20, 2024

Wednesday's big stock stories: What's likely to move the market in the next trading session

August 20, 2024

Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial

August 20, 2024

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

August 15, 2024

Thursday's big stock stories: What’s likely to move the market in the next trading session

August 14, 2024

Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market

August 14, 2024

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

August 13, 2024

After Eli Lilly's blowout quarter, Cramer says not to get too caught up in macro market trends

August 08, 2024

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

August 08, 2024

Thursday's big stock stories: What's likely to move the market in the next trading session

August 07, 2024

5 things to know before the stock market opens Monday

August 05, 2024

Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says

August 02, 2024

Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study

August 01, 2024

Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes

July 31, 2024

Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says

July 30, 2024

Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data

July 29, 2024

European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai

July 26, 2024

Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial

July 25, 2024

Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell

July 18, 2024

CNBC Daily Open: Rising geopolitical risk

July 18, 2024

CNBC Daily Open: Rising geopolitical risk

July 17, 2024

Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche

July 17, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.